MediGene AG operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares MediGene AG with three other
companies in this sector in GERMANY :
Heidelberg Pharma Ag
sales of 7.31 million Euro [US$8.71 million]
of which 83%
was ADC technology sales revenue),
Northern Data AG
(10.16 million Euro [US$12.11 million]
(2.20 million Euro [US$2.62 million]
MediGene AG reported sales of 10.63 million Euro (US$12.67 million)
December of 2019.
increase of 37.1%
versus 2018, when the company's sales were 7.75 million Euro.
Sales of Immunotherapies saw an increase
64.2% in 2019, from
5.98 million Euro to 9.82 million Euro.
Not all segments of MediGene AG experienced an increase in sales in 2019:
sales of Outlincencedproducts fell 56.6% to 693,000.00 Euro.